Go to content
UR Home

IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities

URN to cite this document:
DOI to cite this document:
Harrer, Dennis Christoph ; Bezler, Valerie ; Hartley, Jordan ; Herr, Wolfgang ; Abken, Hinrich
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 15 Jun 2023 12:12


Chimeric antigen receptor (CAR) modified T cells can induce complete remissions in patients with advanced hematological malignancies. Nevertheless, the efficacy is mostly transient and remains so far poor in the treatment of solid tumors. Crucial barriers to long-term CAR T cell success encompass loss of functional capacities known as “exhaustion”, among others. To extend CAR T cell ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons